首页> 美国卫生研究院文献>Pharmaceutics >In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
【2h】

In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms

机译:评估胃滞留剂型的体外和体内测试方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

More than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention remains the holy grail of oral drug delivery. One of the major reasons for the various setbacks in this field is the lack of predictive in vitro and in vivo test methods used during preclinical development. In most cases, human gastrointestinal physiology is not properly considered, which leads to the application of inappropriate in vitro and animal models. Moreover, conditions in the stomach are often not fully understood. Important aspects such as the kinetics of fluid volumes, gastric pH or mechanical stresses have to be considered in a realistic manner, otherwise, the gastroretentive potential as well as drug release of novel formulations cannot be assessed correctly in preclinical studies. This review, therefore, highlights the most important aspects of human gastrointestinal physiology and discusses their potential implications for the evaluation of gastroretentive drug delivery systems.
机译:五十多年前,开发了胃滞留药物输送系统的第一个概念。尽管在该领域进行了广泛的研究,但是还没有单一的配方概念在不同的饮食条件下证明了可靠的胃滞留性。因此,胃滞留仍然是口服药物递送的圣杯。该领域各种挫折的主要原因之一是缺乏临床前开发过程中使用的预测性体外和体内测试方法。在大多数情况下,没有适当考虑人的胃肠生理,这导致应用了不合适的体外和动物模型。而且,胃部的状况常常没有被完全理解。重要的方面,例如体液动力学,胃酸碱度或机械应力,必须以现实的方式加以考虑,否则,在临床前研究中就无法正确评估新型制剂的胃滞留潜力以及药物释放。因此,本综述着重介绍了人类胃肠道生理的最重要方面,并讨论了它们对胃肠道递药系统评估的潜在影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号